P9Z-24146-91965 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-21
Registered in v-safe
2021-04-21
Dose 1 — Moderna
2021-04-21
Survey response — day 0, dose 1
MedDRA: No adverse event — Feeling: Good · Site: Pain

Free text: No

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-04-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-04-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-04-28
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-05-26
Health check-in — day 35, dose 1
Feeling: Good

Adult check-in
2021-06-02
Health check-in — day 42, dose 1
Feeling: Good

Adult check-in
2021-10-20
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2022-04-21
Survey response — 12 months, dose 1
MedDRA: Autoimmune disorder, Uveitis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Autoimmune disease and uveitis

MedDRA releases: 2024-11 · check-in free text available
2022-04-21
Report sent to call center — 12 months, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-04-22
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-21	Moderna

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 7 — day 0, dose 1

2021-04-21

Systemic reaction (other): No

Release 11 — 12 months, dose 1

2022-04-21

Symptoms: Autoimmune disease and uveitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Autoimmune disorder	·	·	✓
SD	Uveitis	·	·	✓
SRO	No adverse event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release